Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$275K Buy
565
+51
+10% +$24K 0.24% 92
2023
Q2
$230K Sell
514
-52
-9% -$26.2K 0.19% 160
2023
Q1
$275K Buy
566
+53
+10% +$26.2K 0.21% 95
2022
Q4
$263K Sell
513
-97
-16% -$51K 0.22% 101
2022
Q3
$296K Hold
610
0.25% 81
2022
Q2
$286K Sell
610
-1
-0.2% -$445 0.24% 88
2022
Q1
$266K Sell
611
-188
-24% -$78.6K 0.22% 105
2021
Q4
$371K Buy
+799
New +$354K 0.27% 76

Other funds holding HUM

Syntax Advisors's HUM Position: Q3 2023 in Review

Syntax Advisors increased its Humana (HUM) stake by 9.9% in Q3 2023, buying an estimated $24K and bringing the position to 565 shares worth $275K. The position accounts for 0.24% of the portfolio, ranked #92.

Syntax Advisors first reported a position in HUM in Q4 2021 and has held it in 8 quarters since. The position peaked at $371K in Q4 2021. 1,086 funds tracked by Wall St. Rank hold HUM as of Q3 2023.

  • Syntax Advisors held 565 shares of Humana worth $275K as of Q3 2023.
  • Syntax Advisors bought 51 Humana shares in Q3 2023, an estimated $24K.
  • Humana made up 0.24% of Syntax Advisors's portfolio in Q3 2023, its #92 holding.
  • Syntax Advisors first reported a position in Humana in Q4 2021 and has held it in 8 quarters since.
  • Syntax Advisors's Humana position peaked at $371K in Q4 2021.
  • 1,086 funds tracked by Wall St. Rank held Humana as of Q3 2023.

Based on Syntax Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.